Online inquiry

IVTScrip™ mRNA-Human ACE2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK9422MR)

This product GTTS-WK9422MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ACE2 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001371415.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 59272
UniProt ID Q9BYF1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACE2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK9422MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK10563MR IVTScrip™ mRNA-Human ABHD14A, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABHD14A
GTTS-WK15913MR IVTScrip™ mRNA-Human AGPAT9, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AGPAT9
GTTS-WK25254MR IVTScrip™ mRNA-Human AQR, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA AQR
GTTS-WK17788MR IVTScrip™ mRNA-Human ALAS2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ALAS2
GTTS-WK26885MR IVTScrip™ mRNA-Human ARSI, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARSI
GTTS-WK16948MR IVTScrip™ mRNA-Human AMD1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AMD1
GTTS-WK9446MR IVTScrip™ mRNA-Human ACSL1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACSL1
GTTS-WK17859MR IVTScrip™ mRNA-Human AMPD3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AMPD3
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →